A new study from researchers at Rutgers University and Columbia University has raised concerns about how depression is sometimes treated.
The study, published in the journal PLOS ONE, found that adults with depression who began treatment with newer antipsychotic drugs had a higher risk of death compared to those who added a second antidepressant instead.
Depression is a very common mental health condition that affects millions of people around the world. It can cause long-lasting sadness, low energy, and difficulty enjoying daily life. Doctors usually treat depression first with antidepressant medications. These drugs help balance chemicals in the brain and can improve mood over time.
However, not everyone responds well to the first antidepressant they try. In many cases, patients may still feel depressed even after taking the medication for several weeks. When this happens, doctors often need to adjust the treatment. This can mean switching to another antidepressant or adding a second medication to help improve the effect.
One common approach is called “augmentation,” where a second drug is added to support the first one. This second drug can either be another antidepressant or a newer type of medication called an antipsychotic. Some commonly used antipsychotics include aripiprazole, quetiapine, and olanzapine.
Antipsychotic drugs were originally developed to treat conditions like schizophrenia and bipolar disorder. Over time, doctors have also started using them to help treat depression, especially in cases where antidepressants alone do not work well. However, these drugs are known to have serious side effects.
For example, antipsychotics can cause weight gain, changes in blood sugar levels, and problems with metabolism. These side effects can increase the risk of other health issues, such as diabetes and heart disease. Previous research has also shown that older adults with dementia who take antipsychotics have a much higher risk of death.
In this new study, researchers wanted to better understand how these risks apply to adults with depression. They examined data from 39,582 Medicaid patients aged between 25 and 64 years.
These patients had all started with one antidepressant but later needed additional treatment. The researchers then compared two groups: those who started a newer antipsychotic and those who added a second antidepressant.
The results showed a clear difference. Patients who began taking an antipsychotic had a 45 percent higher risk of death compared to those who added another antidepressant. To make this easier to understand, the researchers estimated that this increased risk would lead to one extra death for every 265 people treated with an antipsychotic for one year.
Although this study does not prove that antipsychotics directly cause death, it does show a strong link that cannot be ignored. The researchers say that more studies, especially large clinical trials, are needed to confirm these findings. Even so, the results raise important questions about current treatment practices.
Another key issue highlighted by the study is how quickly some patients are moved to stronger medications. Antidepressants usually take about four to six weeks to reach their full effect.
However, in real-world practice, some patients are given antipsychotics before giving the first antidepressant enough time to work. This goes against many treatment guidelines.
The study suggests that doctors should be more careful when deciding to prescribe antipsychotics for depression. While these drugs may help some patients, their benefits are often modest, and their risks can be serious. Safer options, such as trying a different antidepressant or combining two antidepressants, should be considered first.
For people living with depression, this study highlights the importance of understanding treatment choices. Patients should feel comfortable asking their doctors about the risks and benefits of each option. Taking time to explore safer treatments first may help reduce unnecessary risks.
As research continues, studies like this remind us that medical treatments must always be carefully chosen. The goal is not only to improve symptoms but also to protect long-term health and safety.
If you care about mental health, please read studies about 6 foods you can eat to improve mental health, and B vitamins could help prevent depression and anxiety.
For more health information, please see recent studies about how dairy foods may influence depression risk, and results showing Omega-3 fats may help reduce depression.
Copyright © 2026 Knowridge Science Report. All rights reserved.
